IBDEI08Q ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11538,0)
 ;;=365.05^^55^621^38
 ;;^UTILITY(U,$J,358.3,11538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11538,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,11538,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,11538,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,11539,0)
 ;;=365.06^^55^621^40
 ;;^UTILITY(U,$J,358.3,11539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11539,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,11539,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,11539,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,11540,0)
 ;;=365.70^^55^621^31
 ;;^UTILITY(U,$J,358.3,11540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11540,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,11540,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,11540,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,11541,0)
 ;;=365.71^^55^621^17
 ;;^UTILITY(U,$J,358.3,11541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11541,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,11541,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,11541,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,11542,0)
 ;;=365.72^^55^621^18
 ;;^UTILITY(U,$J,358.3,11542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11542,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,11542,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,11542,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,11543,0)
 ;;=365.73^^55^621^30
 ;;^UTILITY(U,$J,358.3,11543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11543,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,11543,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,11543,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,11544,0)
 ;;=365.74^^55^621^14
 ;;^UTILITY(U,$J,358.3,11544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11544,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,11544,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,11544,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,11545,0)
 ;;=V19.11^^55^621^5
 ;;^UTILITY(U,$J,358.3,11545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11545,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,11545,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,11545,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,11546,0)
 ;;=V19.19^^55^621^6
 ;;^UTILITY(U,$J,358.3,11546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11546,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,11546,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,11546,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,11547,0)
 ;;=365.62^^55^621^8
 ;;^UTILITY(U,$J,358.3,11547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11547,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,11547,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,11547,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,11548,0)
 ;;=365.00^^55^621^33
 ;;^UTILITY(U,$J,358.3,11548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11548,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,11548,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,11548,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,11549,0)
 ;;=365.60^^55^621^10
 ;;^UTILITY(U,$J,358.3,11549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11549,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,11549,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,11549,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,11550,0)
 ;;=365.9^^55^621^35
 ;;^UTILITY(U,$J,358.3,11550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11550,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,11550,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,11550,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,11551,0)
 ;;=365.22^^55^621^12
 ;;^UTILITY(U,$J,358.3,11551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11551,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,11551,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,11551,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,11552,0)
 ;;=365.59^^55^621^7
 ;;^UTILITY(U,$J,358.3,11552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11552,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,11552,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,11552,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,11553,0)
 ;;=365.44^^55^621^9
 ;;^UTILITY(U,$J,358.3,11553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11553,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,11553,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,11553,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,11554,0)
 ;;=377.14^^55^621^36
 ;;^UTILITY(U,$J,358.3,11554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11554,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,11554,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,11554,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,11555,0)
 ;;=365.14^^55^621^15
 ;;^UTILITY(U,$J,358.3,11555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11555,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,11555,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,11555,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,11556,0)
 ;;=743.20^^55^621^3
 ;;^UTILITY(U,$J,358.3,11556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11556,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,11556,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,11556,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,11557,0)
 ;;=378.83^^55^622^3
 ;;^UTILITY(U,$J,358.3,11557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11557,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,11557,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,11557,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,11558,0)
 ;;=378.00^^55^622^5
 ;;^UTILITY(U,$J,358.3,11558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11558,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,11558,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,11558,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,11559,0)
 ;;=378.10^^55^622^9
 ;;^UTILITY(U,$J,358.3,11559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11559,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,11559,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,11559,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,11560,0)
 ;;=378.41^^55^622^4
 ;;^UTILITY(U,$J,358.3,11560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11560,1,3,0)
 ;;=3^Esophoria
 ;;^UTILITY(U,$J,358.3,11560,1,4,0)
 ;;=4^378.41
 ;;^UTILITY(U,$J,358.3,11560,2)
 ;;=Esophoria^265435
 ;;^UTILITY(U,$J,358.3,11561,0)
 ;;=378.42^^55^622^8
 ;;^UTILITY(U,$J,358.3,11561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11561,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,11561,1,4,0)
 ;;=4^378.42
 ;;^UTILITY(U,$J,358.3,11561,2)
 ;;=Exophoria^265436
 ;;^UTILITY(U,$J,358.3,11562,0)
 ;;=378.50^^55^622^26
 ;;^UTILITY(U,$J,358.3,11562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11562,1,3,0)
 ;;=3^Strabismus,Paralytic
 ;;^UTILITY(U,$J,358.3,11562,1,4,0)
 ;;=4^378.50
 ;;^UTILITY(U,$J,358.3,11562,2)
 ;;=Strabismus, Paralytic^265442
 ;;^UTILITY(U,$J,358.3,11563,0)
 ;;=378.40^^55^622^12
 ;;^UTILITY(U,$J,358.3,11563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11563,1,3,0)
 ;;=3^Heterophoria
 ;;^UTILITY(U,$J,358.3,11563,1,4,0)
 ;;=4^378.40
 ;;^UTILITY(U,$J,358.3,11563,2)
 ;;=Heterophoria^265433
 ;;^UTILITY(U,$J,358.3,11564,0)
 ;;=378.30^^55^622^13
 ;;^UTILITY(U,$J,358.3,11564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11564,1,3,0)
 ;;=3^Heterotropia
 ;;^UTILITY(U,$J,358.3,11564,1,4,0)
 ;;=4^378.30
 ;;^UTILITY(U,$J,358.3,11564,2)
 ;;=Heterotropia^265406
 ;;^UTILITY(U,$J,358.3,11565,0)
 ;;=378.9^^55^622^27
 ;;^UTILITY(U,$J,358.3,11565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11565,1,3,0)
 ;;=3^Strabismus,Unspecified
 ;;^UTILITY(U,$J,358.3,11565,1,4,0)
 ;;=4^378.9
 ;;^UTILITY(U,$J,358.3,11565,2)
 ;;=Ophthalmoplegia, Unspec^123833
 ;;^UTILITY(U,$J,358.3,11566,0)
 ;;=368.00^^55^622^1
 ;;^UTILITY(U,$J,358.3,11566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11566,1,3,0)
 ;;=3^Amblyopia
 ;;^UTILITY(U,$J,358.3,11566,1,4,0)
 ;;=4^368.00
 ;;^UTILITY(U,$J,358.3,11566,2)
 ;;=^5731
 ;;^UTILITY(U,$J,358.3,11567,0)
 ;;=378.73^^55^622^20
 ;;^UTILITY(U,$J,358.3,11567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11567,1,3,0)
 ;;=3^Ocular Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,11567,1,4,0)
 ;;=4^378.73
 ;;^UTILITY(U,$J,358.3,11567,2)
 ;;=Ocular Myasthenia Gravis^269274
 ;;^UTILITY(U,$J,358.3,11568,0)
 ;;=951.2^^55^622^2
 ;;^UTILITY(U,$J,358.3,11568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11568,1,3,0)
 ;;=3^CN Injury,Fifth
 ;;^UTILITY(U,$J,358.3,11568,1,4,0)
 ;;=4^951.2
 ;;^UTILITY(U,$J,358.3,11568,2)
 ;;=^275898
 ;;^UTILITY(U,$J,358.3,11569,0)
 ;;=378.05^^55^622^6
 ;;^UTILITY(U,$J,358.3,11569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11569,1,3,0)
 ;;=3^Esotropia,Alternating
 ;;^UTILITY(U,$J,358.3,11569,1,4,0)
 ;;=4^378.05
 ;;^UTILITY(U,$J,358.3,11569,2)
 ;;=^265411
 ;;^UTILITY(U,$J,358.3,11570,0)
 ;;=378.01^^55^622^7
 ;;^UTILITY(U,$J,358.3,11570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11570,1,3,0)
 ;;=3^Esotropia,Monocular
 ;;^UTILITY(U,$J,358.3,11570,1,4,0)
 ;;=4^378.01
 ;;^UTILITY(U,$J,358.3,11570,2)
 ;;=^265409
 ;;^UTILITY(U,$J,358.3,11571,0)
 ;;=378.32^^55^622^14
 ;;^UTILITY(U,$J,358.3,11571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11571,1,3,0)
 ;;=3^Hypotropia
 ;;^UTILITY(U,$J,358.3,11571,1,4,0)
 ;;=4^378.32
 ;;^UTILITY(U,$J,358.3,11571,2)
 ;;=^265417
 ;;^UTILITY(U,$J,358.3,11572,0)
 ;;=378.63^^55^622^15
 ;;^UTILITY(U,$J,358.3,11572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11572,1,3,0)
 ;;=3^Limited Duction,Oth Condition
 ;;^UTILITY(U,$J,358.3,11572,1,4,0)
 ;;=4^378.63
 ;;^UTILITY(U,$J,358.3,11572,2)
 ;;=^269273
 ;;^UTILITY(U,$J,358.3,11573,0)
 ;;=378.52^^55^622^19
 ;;^UTILITY(U,$J,358.3,11573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11573,1,3,0)
 ;;=3^Nerve Palsy,Third
 ;;^UTILITY(U,$J,358.3,11573,1,4,0)
 ;;=4^378.52
 ;;^UTILITY(U,$J,358.3,11573,2)
 ;;=^269268
 ;;^UTILITY(U,$J,358.3,11574,0)
 ;;=378.72^^55^622^21
 ;;^UTILITY(U,$J,358.3,11574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11574,1,3,0)
 ;;=3^Ophthalmoplegia External Progressive
 ;;^UTILITY(U,$J,358.3,11574,1,4,0)
 ;;=4^378.72
 ;;^UTILITY(U,$J,358.3,11574,2)
 ;;=^265211
